Cephalexin labels and packages: Difference between revisions
Created page with "__NOTOC__ {{Cephalexin}} {{CMG}};{{AE}}{{AK}} TEVA PHARMACEUTICALS USA Sellersville, PA 18960 Rev. Q 1/2012 PRINCIPAL DISPLAY PANEL {| | image:Cepha1.jpg |} Cephal..." |
No edit summary |
||
| Line 13: | Line 13: | ||
{| | {| | ||
| [[image:Cepha1.jpg]] | | [[image:Cepha1.jpg|400px|thumb]] | ||
|} | |} | ||
| Line 36: | Line 36: | ||
{| | {| | ||
| [[image:Cepha2.jpg]] | | [[image:Cepha2.jpg|400px|thumb]] | ||
|} | |} | ||
| Line 58: | Line 58: | ||
{| | {| | ||
| [[image:Cepha3.jpg]] | | [[image:Cepha3.jpg|400px|thumb]] | ||
|} | |} | ||
| Line 90: | Line 90: | ||
{| | {| | ||
| [[image:Cepha4.jpg]] | | [[image:Cepha4.jpg|400px|thumb]] | ||
|} | |} | ||
| Line 122: | Line 122: | ||
{| | {| | ||
| [[image:Cepha5.jpg]] | | [[image:Cepha5.jpg|400px|thumb]] | ||
|} | |} | ||
| Line 144: | Line 144: | ||
{| | {| | ||
| [[image:Cepha6.png]] | | [[image:Cepha6.png|400px|thumb]] | ||
|} | |} | ||
Latest revision as of 16:26, 2 January 2014
| Cephalexin |
|---|
| CEPHALEXIN®,KEFLEX® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Overdosage |
| Dosage and Administration |
| How Supplied |
| Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
TEVA PHARMACEUTICALS USA
Sellersville, PA 18960
Rev. Q 1/2012
PRINCIPAL DISPLAY PANEL
 |
Cephalexin Capsules USP 250 mg 100s Label Text
NDC 0093-3145-01
CEPHALEXIN
Capsules USP
250 mg*
Rx only
100 CAPSULES
TEVA
PRINCIPAL DISPLAY PANEL
 |
Cephalexin Capsules USP 500 mg 100s Label Text
NDC 0093-3147-01
CEPHALEXIN
Capsules USP
500 mg*
Rx only
100 CAPSULES
TEVA
PRINCIPAL DISPLAY PANEL
 |
Cephalexin FOS USP 125 mg per 5 mL 100 mL Label Text
NDC 0093-4175-73
CEPHALEXIN
for Oral Suspension, USP
125 mg per 5 mL
when reconstituted according to directions.
Usual Pediatric Dose: 25 to 50 mg per kg a day in four
divided doses. For more severe infections, dose may be
doubled. See accompanying literature.
Rx only
FOR ORAL USE ONLY
100 mL (when mixed)
TEVA
PRINCIPAL DISPLAY PANEL
 |
Cephalexin FOS USP 250 mg per 5 mL 100 mL Label Text
NDC 0093-4177-73
CEPHALEXIN
for Oral Suspension, USP
250 mg per 5 mL
when reconstituted according to directions.
Usual Pediatric Dose: 25 to 50 mg per kg a day in four
divided doses. For more severe infections, dose may be
doubled. See accompanying literature.
Rx only
FOR ORAL USE ONLY
100 mL (when mixed)
TEVA
PRINCIPAL DISPLAY PANEL
 |
Cephalexin Tablets USP 250 mg 100s Label Text
NDC 0093-2238-01
CEPHALEXIN
Tablets USP
250 mg*
Rx only
100 TABLETS
TEVA
PRINCIPAL DISPLAY PANEL
 |
Cephalexin Tablets USP 500 mg 100s Label Text NDC 0093-2240-01
CEPHALEXIN
Tablets USP
500 mg*
Rx only
100 TABLETS
TEVA
References
http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/050405s097lbl.pdf